tiprankstipranks
Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments
Company Announcements

Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments

Don't Miss our Black Friday Offers:

Scilex Holding Company ( (SCLX) ) has issued an update.

Scilex Holding Company has reached an agreement with Endeavor Distribution LLC to satisfy a $10 million loan from FSF 33433 LLC by delivering a specified quantity of their ZTlido product. This agreement not only settles the debt but further strengthens Scilex’s partnership with Endeavor, which will distribute Scilex’s non-opioid pain management products across the U.S., potentially expanding their market reach. The deal underlines Scilex’s commitment to increasing access to their non-opioid treatments, a move that is expected to benefit thousands of patients suffering from acute and chronic pain.

See more insights into SCLX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskScilex Holding Plans Merger to Boost Semnur Value
TheFlyScilex announces successful end of Phase II meeting with FDA
TipRanks Auto-Generated NewsdeskScilex Holding Sets Dividend for Preferred Stock Exchange
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App